🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

146,64 USD

Máx. histórico

157,29

209 días

Split 2:1 del 28/01/2013

Caída desde máximo

-6,77%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-2,88%

Cierre anterior

151,00

Rango de hoy

145,45 – 148,65

Volumen hoy

6.023.444

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 3 horas
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,20%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
28/01/2013 2:1
25/06/2007 2:1
07/09/2004 2:1
08/03/2002 2:1
22/02/2001 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/01/2009 23,88 24,13 23,45 23,83 -0,25% 2,85% 12.793.200
09/01/2009 24,55 24,55 23,68 23,89 -2,25% 3,54% 13.731.000
08/01/2009 24,34 24,44 23,81 24,44 +0,31% 2,59% 15.022.400
07/01/2009 24,50 25,00 24,08 24,36 -1,83% 3,78% 15.564.800
06/01/2009 25,61 25,63 24,50 24,82 -2,69% 4,39% 17.652.600
05/01/2009 25,88 25,99 25,21 25,50 -2,26% 3,03% 15.666.000
02/01/2009 25,45 26,18 25,33 26,09 +2,03% 3,32% 11.256.400
31/12/2008 25,74 26,13 25,52 25,57 -0,37% 2,39% 12.030.600
30/12/2008 25,15 25,71 25,13 25,67 +2,89% 2,33% 13.377.800
29/12/2008 25,35 25,35 24,59 24,95 -0,24% 3,02% 8.565.600
26/12/2008 25,18 25,26 24,87 25,01 -0,89% 1,55% 5.257.000
24/12/2008 25,14 25,49 24,91 25,23 +0,92% 2,31% 6.005.000
23/12/2008 25,07 25,60 24,90 25,00 -0,60% 2,77% 18.417.600
22/12/2008 24,99 25,18 24,54 25,15 +1,31% 2,56% 17.024.000
19/12/2008 24,54 25,14 24,28 24,83 +1,78% 3,52% 33.040.200
18/12/2008 23,82 24,89 23,77 24,39 +2,37% 4,68% 20.594.800
17/12/2008 23,77 24,44 23,64 23,83 -0,46% 3,35% 15.181.200
16/12/2008 22,61 23,98 22,61 23,94 +7,94% 6,04% 28.325.800
15/12/2008 22,48 22,78 22,08 22,18 -1,51% 3,11% 11.386.600
12/12/2008 21,79 22,61 21,53 22,52 +2,18% 4,98% 12.710.000
11/12/2008 22,65 23,00 21,95 22,04 -3,36% 4,64% 14.964.200
10/12/2008 22,60 23,05 22,30 22,80 +1,72% 3,32% 14.163.000
09/12/2008 23,18 23,55 22,20 22,42 -3,94% 5,83% 20.420.800
08/12/2008 23,93 24,01 22,96 23,34 -1,52% 4,39% 20.750.000
05/12/2008 22,59 23,75 22,07 23,70 +4,04% 7,41% 23.150.800
04/12/2008 22,70 23,44 22,51 22,78 -1,34% 4,12% 16.502.800
03/12/2008 21,84 23,20 21,72 23,09 +4,72% 6,76% 22.621.400
02/12/2008 21,43 22,17 21,38 22,05 +3,84% 3,71% 17.188.200
01/12/2008 21,86 22,10 21,23 21,23 -5,20% 3,98% 15.233.600
28/11/2008 22,38 22,50 22,02 22,40 -0,58% 2,15% 5.009.400